{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:32:16Z","timestamp":1790281936672,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s12664-018-0859-4","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T01:46:44Z","timestamp":1529545604000},"page":"215-225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis"],"prefix":"10.1007","volume":"37","author":[{"given":"Cyriac Abby","family":"Philips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Phadke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shatakshi","family":"Ranade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Augustine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,21]]},"reference":[{"key":"859_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","volume":"150","author":"DW Crabb","year":"2016","unstructured":"Crabb DW, Bataller R, Chalasani NP, et al. Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology. 2016;150:785\u201390.","journal-title":"Gastroenterology"},{"key":"859_CR2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","volume":"75","author":"WC Maddrey","year":"1978","unstructured":"Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978;75:193\u20139.","journal-title":"Gastroenterology"},{"key":"859_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/gut.2010.224097","volume":"60","author":"P Mathurin","year":"2011","unstructured":"Mathurin P, O\u2019Grady J, Carithers RL, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut. 2011;60:255\u201360.","journal-title":"Gut"},{"key":"859_CR4","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1053\/j.gastro.2016.12.019","volume":"152","author":"N Vergis","year":"2017","unstructured":"Vergis N, Knapp S, Maurice J, et al. In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and is associated with high circulating levels of bacterial DNA. Gastroenterology. 2017;152:1068\u201377.","journal-title":"Gastroenterology"},{"key":"859_CR5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/TP.0000000000001156","volume":"100","author":"G Addolorato","year":"2016","unstructured":"Addolorato G, Bataller R, Burra P, et al. Liver transplantation for alcoholic liver disease. Transplantation. 2016;100:981\u20137.","journal-title":"Transplantation"},{"key":"859_CR6","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3109\/00365521.2011.603160","volume":"46","author":"J Hartl","year":"2011","unstructured":"Hartl J, Scherer MN, Loss M, et al. Strong predictors for alcohol recidivism after liver transplantation: non-acceptance of the alcohol problem and abstinence of <3 months. Scand J Gastroenterol. 2011;46:1257\u201366.","journal-title":"Scand J Gastroenterol"},{"key":"859_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12072-017-9790-5","volume":"11","author":"SS Sidhu","year":"2017","unstructured":"Sidhu SS, Goyal O, Kishore H, Sidhu S. New paradigms in management of alcoholic hepatitis: a review. Hepatol Int. 2017;11:255\u201367.","journal-title":"Hepatol Int"},{"key":"859_CR8","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.jhep.2016.11.008","volume":"66","author":"G Ferrere","year":"2017","unstructured":"Ferrere G, Wrzosek L, Cailleux F, et al. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice. J Hepatol. 2017;66:806\u201315.","journal-title":"J Hepatol"},{"key":"859_CR9","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","volume":"15","author":"CA Philips","year":"2017","unstructured":"Philips CA, Pande A, Shasthry SM, et al. Healthy donor fecal microbiota transplantation in steroid ineligible severe alcoholic hepatitis: a pilot study. Clin Gastroenterol Hepatol. 2017;15:600\u20132.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"859_CR10","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","volume":"65","author":"M Llopis","year":"2016","unstructured":"Llopis M, Cassard AM, Wrzosek L, et al. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut. 2016;65:830\u20139.","journal-title":"Gut"},{"key":"859_CR11","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1053\/j.gastro.2015.12.038","volume":"150","author":"C Moreno","year":"2016","unstructured":"Moreno C, Deltenre P, Senterre C, et al. Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids. Gastroenterology. 2016;150:903\u201310.e8.","journal-title":"Gastroenterology"},{"key":"859_CR12","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","volume":"372","author":"MR Thursz","year":"2015","unstructured":"Thursz MR, Richardson P, Allison M, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372:1619\u201328.","journal-title":"N Engl J Med"},{"key":"859_CR13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","volume":"57","author":"L Zhu","year":"2013","unstructured":"Zhu L, Baker SS, Gill C, et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology. 2013;57:601\u20139.","journal-title":"Hepatology"},{"key":"859_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00535-017-1368-4","volume":"53","author":"T Nakahara","year":"2018","unstructured":"Nakahara T, Hyogo H, Ono A, et al. Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease. J Gastroenterol. 2018;53:269\u201380.","journal-title":"J Gastroenterol"},{"key":"859_CR15","doi-asserted-by":"publisher","first-page":"34055","DOI":"10.1038\/srep34055","volume":"6","author":"Y Chen","year":"2016","unstructured":"Chen Y, Ji F, Guo J, Shi D, Fang D, Lib L. Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology. Sci Rep. 2016;6:34055.","journal-title":"Sci Rep"},{"key":"859_CR16","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/hep.28737","volume":"64","author":"G Dam","year":"2016","unstructured":"Dam G, Vilstrup H, Watson H, Jepsen P. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites. Hepatology. 2016;64:1265\u201372.","journal-title":"Hepatology"},{"key":"859_CR17","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/hep.24423","volume":"54","author":"Y Chen","year":"2011","unstructured":"Chen Y, Yang F, Lu H, et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology. 2011;54:562\u201372.","journal-title":"Hepatology"},{"key":"859_CR18","doi-asserted-by":"publisher","first-page":"G168","DOI":"10.1152\/ajpgi.00190.2011","volume":"302","author":"JS Bajaj","year":"2012","unstructured":"Bajaj JS, Ridlon JM, Hylemon PB, et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol. 2012;302:G168\u201375.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"859_CR19","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","volume":"60","author":"JS Bajaj","year":"2014","unstructured":"Bajaj JS, Hylemon PB, Heuman DM, et al. The cirrhosis dysbiosis ratio defines changes in the gut microbiome associated with cirrhosis and its complications. Hepatology. 2014;60:940\u20137.","journal-title":"Hepatology"},{"key":"859_CR20","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1126\/science.aad8852","volume":"29","author":"SS Li","year":"2016","unstructured":"Li SS, Zhu A, Benes V, et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science. 2016;29:586\u20139.","journal-title":"Science"},{"key":"859_CR21","volume-title":"Amino acid biosynthesis\u2014pathways, regulation and metabolic engineering. Microbiology Monographs","author":"T Oikawa","year":"2006","unstructured":"Oikawa T. Alanine, aspartate, and asparagine metabolism in microorganisms. In: Wendisch VF. eds. Amino acid biosynthesis\u2014pathways, regulation and metabolic engineering. Microbiology Monographs. Vol 5. 2006. Springer, Berlin, Heidelberg."},{"key":"859_CR22","doi-asserted-by":"crossref","unstructured":"Calder PC. Branched-chain amino acids and immunity. J Nutr. 2006;136 1 Suppl:288S\u201393S.","DOI":"10.1093\/jn\/136.1.288S"},{"key":"859_CR23","doi-asserted-by":"publisher","first-page":"7620","DOI":"10.3748\/wjg.v19.i43.7620","volume":"19","author":"K Tajiri","year":"2013","unstructured":"Tajiri K, Shimizu Y. Branched-chain amino acids in liver diseases. World J Gastroenterol. 2013;19:7620\u20139.","journal-title":"World J Gastroenterol"},{"key":"859_CR24","doi-asserted-by":"crossref","unstructured":"Neuman MG, Maor Y, Nanau RM, et al. Alcoholic liver disease: role of cytokines. Biomolecules. 2015; 5: 2023\u201334.","DOI":"10.3390\/biom5032023"},{"key":"859_CR25","doi-asserted-by":"publisher","first-page":"35610","DOI":"10.1038\/srep35610","volume":"6","author":"G Odena","year":"2016","unstructured":"Odena G, Chen J, Lozano JJ, et al. LPS-TLR4 pathway mediates ductular cell expansion in alcoholic hepatitis. Sci Rep. 2016;6:35610.","journal-title":"Sci Rep"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12664-018-0859-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-018-0859-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-018-0859-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T19:21:35Z","timestamp":1561058495000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12664-018-0859-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["859"],"URL":"https:\/\/doi.org\/10.1007\/s12664-018-0859-4","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"6 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"CAP, NP, KG, SR, and PA declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were by the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}